Identification of viable TCDD access pathways to human AhR PAS-B ligand binding domain

被引：0
|
作者：
Casalegno, Mosè [1 ]
Raos, Guido [1 ]
Sello, Guido [2 ]
机构：
[1] Dipartimento di Chimica, Materiali e Ingegneria Chimica G. Natta, Politecnico di Milano, Via L. Mancinelli 7, Milano,20131, Italy
[2] Dipartimento di Chimica, Università degli Studi di Milano, via Golgi 19, Milano,I-20133, Italy
来源：
Journal of Molecular Graphics and Modelling | 2021年 / 105卷
关键词：
89;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 42 条
  • [31] Identification of novel ligands and insight into the structural switch between agonist and antagonist activity from an optimized model of the human aryl hydrocarbon receptor ligand binding domain
    Perkins, Arden
    Phillips, Jessica
    Kopparapu, Prasad R.
    Kerkvliet, Nancy I.
    Tanguay, Robert L.
    Perdew, Gary
    Kolluri, Siva K.
    Bisson, William H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [32] Over-expression and purification of isotopically labeled recombinant ligand-binding domain of orphan nuclear receptor human B1-binding factor/human liver receptor homologue 1 for NMR studies
    Chen, X
    Tong, XT
    Xie, YH
    Wang, Y
    Ma, JB
    Gao, DM
    Wu, HM
    Chen, HB
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 45 (01) : 99 - 106
  • [33] IDENTIFICATION OF THE LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR-BINDING DOMAIN OF HUMAN APOLIPOPROTEIN-B-100 (APOB-100)
    HOSPATTANKAR, AV
    LAW, SW
    LACKNER, KJ
    BREWER, HB
    CIRCULATION, 1985, 72 (04) : 10 - 10
  • [34] PARTIAL FUNCTIONAL MAPPING OF THE HUMAN INTERLEUKIN-8 TYPE-A RECEPTOR - IDENTIFICATION OF A MAJOR LIGAND-BINDING DOMAIN (VOL 268, PG 18549, 1993)
    HEBERT, CA
    CHUNTHARAPAI, A
    SMITH, M
    COLBY, T
    KIM, J
    HORUK, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (23) : 16520 - 16520
  • [35] Solution NMR structure and ligand identification of human Gas7 SH3 domain reveal a typical SH3 fold but a non-canonical ligand-binding mode
    Nie, Yao
    Zhu, Jiang
    Ramelot, Theresa A.
    Kennedy, Michael A.
    Liu, Maili
    He, Ting
    Yang, Yunhuang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 516 (04) : 1190 - 1195
  • [36] Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket
    Malherbe, P
    Mutel, V
    Broger, C
    Perin-Dureau, F
    Kemp, JA
    Neyton, J
    Paoletti, P
    Kew, JNC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03): : 897 - 905
  • [37] PROBING THE HUMAN RECEPTOR FOR C5A ANAPHYLATOXIN WITH SITE-DIRECTED ANTIBODIES - IDENTIFICATION OF A POTENTIAL LIGAND-BINDING SITE ON THE NH2-TERMINAL DOMAIN
    OPPERMANN, M
    RAEDT, U
    HEBELL, T
    SCHMIDT, B
    ZIMMERMANN, B
    GOTZE, O
    JOURNAL OF IMMUNOLOGY, 1993, 151 (07): : 3785 - 3794
  • [38] The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
    Kelm, S
    Gerlach, J
    Brossmer, R
    Danzer, CP
    Nitschke, L
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09): : 1207 - 1213
  • [39] Erratum: Identification of the ligand-binding domain of human vascular-endothelial-growth-factor receptor Flt-I (Biotechnology and Applied Biochemistry (2001) 34 (199-204))
    Ma, L.
    Wang, X.
    Zhang, Z.
    Zhou, X.
    Chen, A.
    Yao, L.
    Biotechnology and Applied Biochemistry, 2002, 35 (03)
  • [40] IDENTIFICATION OF PUTATIVE LIGAND-BINDING SITES WITHIN I-DOMAIN OF INTEGRIN ALPHA-2-BETA-1 (VLA-2, CD49B/CD29)
    KAMATA, T
    PUZON, W
    TAKADA, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (13) : 9659 - 9663
12345